New role to drive growth of CliniSys products and services globally 

Mark Spencer has joined CliniSys as Senior Vice President of Global Strategy. With 25-years’ experience in the life sciences and healthcare IT industry, Spencer will be charged with driving growth globally. 

Moving forward 

As the world looks to improve public health now and after the pandemic, Spencer will work closely with the senior leadership team to realise CliniSys’ vision to support its customers both inside and beyond the boundaries of the clinical laboratory to embrace a new wave of community laboratories and digital diagnostics in healthcare, toxicology, agriculture, water and environmental testing. 

Official comments 

“CliniSys is at an exciting stage of growth after its recent M&A activity, priming it to deliver the integrated and holistic laboratory diagnostics that will drive the next wave of innovation in disease surveillance and tracking,” said Spencer. “That is why I am looking forward to returning to the company and driving the strategies that will accelerate our growth in key regions globally.” 

“Mark brings with him a deep knowledge of healthcare and technology, and a wealth of experience leading an impressive list of successful business transformations in the sector,” said Michael Simpson, CEO of CliniSys.  

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free